AZTA
Price
$35.56
Change
-$0.71 (-1.96%)
Updated
Nov 28 closing price
Capitalization
1.63B
74 days until earnings call
Intraday BUY SELL Signals
MASS
Price
$6.35
Change
-$0.06 (-0.94%)
Updated
Nov 28 closing price
Capitalization
231.82M
101 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

AZTA vs MASS

Header iconAZTA vs MASS Comparison
Open Charts AZTA vs MASSBanner chart's image
Azenta
Price$35.56
Change-$0.71 (-1.96%)
Volume$355.85K
Capitalization1.63B
908 Devices
Price$6.35
Change-$0.06 (-0.94%)
Volume$355.17K
Capitalization231.82M
AZTA vs MASS Comparison Chart in %
AZTA
Daily Signal:
Gain/Loss:
MASS
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
AZTA vs. MASS commentary
Nov 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AZTA is a StrongBuy and MASS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 29, 2025
Stock price -- (AZTA: $35.56 vs. MASS: $6.35)
Brand notoriety: AZTA and MASS are both not notable
AZTA represents the Pharmaceuticals: Other, while MASS is part of the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: AZTA: 65% vs. MASS: 93%
Market capitalization -- AZTA: $1.63B vs. MASS: $231.82M
AZTA [@Pharmaceuticals: Other] is valued at $1.63B. MASS’s [@Medical/Nursing Services] market capitalization is $231.82M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $203.3B to $0. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $224.14B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $12B. The average market capitalization across the [@Medical/Nursing Services] industry is $5.82B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AZTA’s FA Score shows that 0 FA rating(s) are green whileMASS’s FA Score has 0 green FA rating(s).

  • AZTA’s FA Score: 0 green, 5 red.
  • MASS’s FA Score: 0 green, 5 red.
According to our system of comparison, AZTA is a better buy in the long-term than MASS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AZTA’s TA Score shows that 6 TA indicator(s) are bullish while MASS’s TA Score has 5 bullish TA indicator(s).

  • AZTA’s TA Score: 6 bullish, 4 bearish.
  • MASS’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, AZTA is a better buy in the short-term than MASS.

Price Growth

AZTA (@Pharmaceuticals: Other) experienced а +1.92% price change this week, while MASS (@Medical/Nursing Services) price change was +7.45% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +2.63%. For the same industry, the average monthly price growth was +3.38%, and the average quarterly price growth was +5.77%.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +6.78%. For the same industry, the average monthly price growth was +0.32%, and the average quarterly price growth was +13.36%.

Reported Earning Dates

AZTA is expected to report earnings on Feb 11, 2026.

MASS is expected to report earnings on Mar 10, 2026.

Industries' Descriptions

@Pharmaceuticals: Other (+2.63% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

@Medical/Nursing Services (+6.78% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AZTA($1.63B) has a higher market cap than MASS($232M). MASS YTD gains are higher at: 188.636 vs. AZTA (-28.880). AZTA has higher annual earnings (EBITDA): 11.3M vs. MASS (-68.12M). AZTA has more cash in the bank: 319M vs. MASS (119M). MASS has less debt than AZTA: MASS (4.43M) vs AZTA (52.6M). AZTA has higher revenues than MASS: AZTA (669M) vs MASS (65.6M).
AZTAMASSAZTA / MASS
Capitalization1.63B232M703%
EBITDA11.3M-68.12M-17%
Gain YTD-28.880188.636-15%
P/E Ratio68.38N/A-
Revenue669M65.6M1,020%
Total Cash319M119M268%
Total Debt52.6M4.43M1,187%
FUNDAMENTALS RATINGS
AZTA: Fundamental Ratings
AZTA
OUTLOOK RATING
1..100
24
VALUATION
overvalued / fair valued / undervalued
1..100
62
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
87
PRICE GROWTH RATING
1..100
43
P/E GROWTH RATING
1..100
39
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AZTAMASS
RSI
ODDS (%)
Bearish Trend 1 day ago
64%
Bullish Trend 1 day ago
71%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
73%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
73%
Bullish Trend 1 day ago
78%
MACD
ODDS (%)
Bullish Trend 1 day ago
64%
Bullish Trend 1 day ago
74%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
70%
Bullish Trend 1 day ago
80%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
75%
Bearish Trend 1 day ago
87%
Advances
ODDS (%)
Bullish Trend 4 days ago
70%
Bullish Trend 4 days ago
79%
Declines
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
88%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
80%
Bullish Trend 1 day ago
89%
Aroon
ODDS (%)
Bullish Trend 1 day ago
70%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
AZTA
Daily Signal:
Gain/Loss:
MASS
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MNSAF4.210.31
+7.90%
Mineros S.A.
CVVUF0.47N/A
+1.05%
CanAlaska Uranium Ltd.
QUTIF0.27N/A
N/A
Questor Technology, Inc.
VLMTY37.22N/A
N/A
Valmet OYJ
BSQKZ79.08N/A
N/A
Block, Inc.

AZTA and

Correlation & Price change

A.I.dvisor indicates that over the last year, AZTA has been loosely correlated with IQV. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if AZTA jumps, then IQV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AZTA
1D Price
Change %
AZTA100%
-1.96%
IQV - AZTA
60%
Loosely correlated
-0.77%
RVTY - AZTA
59%
Loosely correlated
-0.24%
A - AZTA
59%
Loosely correlated
-0.56%
MTD - AZTA
59%
Loosely correlated
-0.66%
BRKR - AZTA
58%
Loosely correlated
-0.45%
More